compounded semaglutide companies Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27% Hims & Hers will stop

GLP-1 receptor agonists show measurable effects on cardiovascular health, including potential blood pressure reduction

GLP-1 treatments like semaglutide can benefit autoimmune patients, but they aren't a replacement for your current inflammation medications

Lilly plans regulatory submissions in 2025 for obesity and in 2026 for type 2 diabetes

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)

Learn about the dangers these products can pose related to accidental ingestion.

Learn about the safety of using acetaminophen with Ozempic, Wegovy, or Rybelsus, including dosing guidelines, potential considerations, and when to contact your healthcare provider for personalized advice.